ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,345 | -74.2% | 25,378 | 0.0% | 0.00% | – |
| Q2 2023 | $12,943 | -21.4% | 25,378 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $16,473 | -62.6% | 25,378 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $44,000 | +41.9% | 25,378 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $31,000 | +72.2% | 25,378 | -8.6% | 0.00% | +100.0% |
| Q1 2022 | $18,000 | -40.0% | 27,760 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $30,000 | -41.2% | 27,760 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $51,000 | -1.9% | 27,760 | 0.0% | 0.00% | -77.8% |
| Q4 2018 | $52,000 | -41.6% | 27,760 | 0.0% | 0.02% | -10.0% |
| Q3 2018 | $89,000 | +6.0% | 27,760 | 0.0% | 0.02% | -31.0% |
| Q2 2018 | $84,000 | -32.8% | 27,760 | -0.2% | 0.03% | +38.1% |
| Q1 2018 | $125,000 | -2.3% | 27,803 | +0.2% | 0.02% | +31.2% |
| Q4 2017 | $128,000 | – | 27,760 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |